Business / Finance

RSS

LifePoint Hospitals fourth quarter revenues increase 14.3% to $893.3 million

LifePoint Hospitals, Inc. today announced results for the fourth quarter and year ended December 31, 2012.

15 Feb 2013

Shengtai second quarter net sales increase 49.31% to $64,103,621

Shengtai Pharmaceutical, Inc., a manufacturer and distributor in China of glucose and starch as pharmaceutical raw materials and other starch and glucose products, today reported financial results for the three months ended December 31, 2012.

15 Feb 2013

Third Rock Ventures announces formation of Jounce Therapeutics

Third Rock Ventures, LLC today announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is focused on the discovery and development of first-in-class cancer immunotherapies designed to harness the patient's immune system to seek out and attack cancerous cells and tumors.

15 Feb 2013

Cardinal Health announces plans to acquire AssuraMed

Cardinal Health today announced plans to acquire privately held AssuraMed, a leading provider of medical supplies to patients in the home, for $2.07 billion, or $1.94 billion, net of the present value of tax benefits.

15 Feb 2013

AccentHealth purchases Everwell waiting room television network

AccentHealth, the nation's largest media network at the Point-of-Care, announced today it has purchased the Everwell waiting room television network, a division of MediVista Media, LLC.

15 Feb 2013

Masimo's total fourth quarter revenue increases 18% to $132.2 million

Masimo today announced its financial results for the fourth quarter and year ended December 29, 2012.

15 Feb 2013

Ingenuity Systems receives HIPAA Certification

Ingenuity Systems, a leading provider of biomedical information and analysis solutions, today announced that it has passed the Health Insurance Portability and Accountability Act (HIPAA) audit, confirming that Ingenuity's data center and Ingenuity Variant Analysis are in compliance with relevant Federal Regulations.

15 Feb 2013

National Mentor Holdings first quarter revenues increase 7.5% to $294.9 million

National Mentor Holdings, Inc. today announced its financial results for the first quarter ended December 31, 2012.

15 Feb 2013

SQI Diagnostics reports net loss of $1,563,000 for quarter-ended December 31, 2012

SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.

15 Feb 2013

Health care staff can use QPID's intelligence engine to gain better insights from EHRs

QPID Inc. launched today, delivering a new health record intelligence platform and web-based applications that enable health care institutions and clinicians to gain better insights from any Electronic Health Record (EHR).

15 Feb 2013

SunLink second quarter consolidated net revenues decrease 4.0% to $27,850,000

SunLink Health Systems, Inc. today announced net earnings for its second fiscal quarter ended December 31, 2012 of $3,935,000, or $0.42 per fully diluted share, compared to a net loss of $935,000, or a loss of $0.10 per fully diluted share, for the quarter ended December 31, 2011.

14 Feb 2013

Innophos reports net sales of $209 million for fourth quarter 2012

Innophos Holdings, Inc., a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets, today announced its financial results for the fourth quarter and full year 2012.

14 Feb 2013

Regeneron fourth quarter total revenues increase to $415 million

Regeneron Pharmaceuticals, Inc. today announced financial and operating results for the fourth quarter and full year 2012 and provided an update on development programs.

14 Feb 2013

Tianyin Pharmaceutical second quarter revenue decreases 3.3% to $17.6 million

Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for second quarter of the fiscal year 2013.

14 Feb 2013

Medgenics closes public offering of 5,600,000 shares of common stock and warrants

Medgenics, Inc., the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces yesterday's closing of an underwritten public offering of 5,600,000 shares of common stock and Series 2013-A warrants to purchase up to an aggregate of 2,800,000 shares of common stock.

14 Feb 2013

Targacept reports net loss of $15.9 million for fourth quarter 2012

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today reported its financial results for the fourth quarter and year ended December 31, 2012.

14 Feb 2013

Weight Watchers International fourth quarter revenues increase 1.7% to $407.9 million

Weight Watchers International, Inc. today announced its fiscal 2012 results for the fourth quarter and full year and provided full year fiscal 2013 earnings guidance.

14 Feb 2013

ArthroCare fourth quarter total revenue increases 4.9% to $96.9 million

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2012.

14 Feb 2013

Dyax fourth quarter total revenues increase to $16.0 million

Dyax Corp. today announced financial results for the fourth quarter and year ended December 31, 2012.

14 Feb 2013

Antibody therapeutics targeting GPCRs to be developed by alliance between MorphoSys and Heptares

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and UK-based Heptares Therapeutics, the leading GPCR drug discovery and development company, have signed an agreement to discover novel antibody therapeutics targeting G protein-coupled receptors (GPCRs), which are membrane proteins involved in a broad range of biological processes and diseases.

13 Feb 2013